Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2023 12:12 ET | Source: Trethera Corporation

Trethera Announces Poster Presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
January 05, 2023 09:00 ET | Source: JAPAN HOUSE Los Angeles

JAPAN HOUSE Los Angeles Presents “Designing With Disaster: Stories From Seven Regenerative Cities”

LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles, a Japanese cultural destination in the heart of Hollywood, announces its upcoming exhibition “Designing with Disaster: Stories...
December 20, 2022 03:30 ET | Source: NewHydrogen, Inc.

NewHydrogen reports progress in its quest to lower the cost of producing green hydrogen

NewHydrogen CEO highlights the company’s milestones, and outlines next steps SANTA CLARITA, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC: NEWH), a developer of a breakthrough...
November 08, 2022 10:00 ET | Source: NeuroSigma, Inc.

NeuroSigma Announces that Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD

Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in the United Kingdom Trials sponsored by the...
October 19, 2022 12:17 ET | Source: Trethera Corporation

Trethera Receives $1.6 Million National Eye Institute Grant for Continued Advancement of TRE-515 Optic Neuritis Program

LOS ANGELES, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
October 04, 2022 12:23 ET | Source: Trethera Corporation

Trethera Announces Multiple Sclerosis Treatment Poster Presentation at the American Neurological Association Annual Meeting

LOS ANGELES, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
September 13, 2022 12:00 ET | Source: SFM, LLC d/b/a Sprouts Farmers Market

Sprouts Farmers Market Aligns with Arizona State University, University of California, Los Angeles, University of Southern California, and University of Texas to Empower Women’s Sports and Health

PHOENIX, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Sprouts Farmers Market today announced a complement to its long-term commitment and investment to women’s athletics through individual sponsorship...
September 07, 2022 12:37 ET | Source: Trethera Corporation

Trethera and UCLA Publish Data Demonstrating TRE-515 Ability to Control and Improve Multiple Sclerosis Symptoms in Mouse Models

LOS ANGELES, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
August 17, 2022 08:00 ET | Source: Kronos Fusion Energy

Revolutionary Aneutronic Fusion Energy Generator Being Built By Kronos Fusion Energy With Carl Weggel Leading Its Design

ARLINGTON, Va., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Carl Weggel—a 50-year persistent advocate of the compact, ultra-high-field tokamak—is on a mission to commercialize fusion energy through Kronos's...
August 16, 2022 14:00 ET | Source: Kronos Fusion Energy

Carl Weggel Joins Kronos Fusion Energy and Designs S.M.A.R.T, a Revolutionary Fusion Energy Generator Being Built by Kronos Fusion Energy

ARLINGTON, Va., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Carl Weggel--a 50-year persistent advocate of the compact, ultra-high-field tokamak--is on a mission to commercialize fusion energy through Kronos's...